NEW YORK (GenomeWeb) – Canadian diagnostic developer GeneNews said today that it has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.

Under the agreement, Milost will initially purchase up to $3 million in unsecured convertible notes from GeneNews. The notes will be convertible at a price equal to the five-day volume-weighted average price of common shares of GeneNews on the Toronto Stock Exchange on the day of the draw-down notice, plus a 200 percent premium.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.